Current Cancer Drug Targets
Impact Factor & Key Scientometrics

Current Cancer Drug Targets
Overview

Impact Factor

3.428

H Index

103

Impact Factor

2.763

I. Basic Journal Info

Country

United Arab Emirates
Journal ISSN: 15680096, 18735576
Publisher: Bentham Science Publishers
History: 2001-ongoing
Journal Hompage: Link
How to Get Published:

Research Categories

Scope/Description:

Current Cancer Drug Targets aims to cover all the latest and outstanding developments on the medicinal chemistry, pharmacology, molecular biology, genomics and biochemistry of contemporary molecular drug targets involved in cancer, e.g. disease specific proteins, receptors, enzymes, genes. Current Cancer Drug Targets publishes original research articles and a series of timely in-depth reviews written by leaders in the field covering a range of current topics on drug targets involved in cancer. As the discovery, identification, characterization and validation of novel human drug targets for anti-cancer drug discovery continues to grow; this journal has become essential reading for all pharmaceutical scientists involved in drug discovery and development.

II. Science Citation Report (SCR)



Current Cancer Drug Targets
SCR Impact Factor

Current Cancer Drug Targets
SCR Journal Ranking

Current Cancer Drug Targets
SCImago SJR Rank

SCImago Journal Rank (SJR indicator) is a measure of scientific influence of scholarly journals that accounts for both the number of citations received by a journal and the importance or prestige of the journals where such citations come from.

0.972

Current Cancer Drug Targets
Scopus 2-Year Impact Factor Trend

Note: impact factor data for reference only

Current Cancer Drug Targets
Scopus 3-Year Impact Factor Trend

Note: impact factor data for reference only

Current Cancer Drug Targets
Scopus 4-Year Impact Factor Trend

Note: impact factor data for reference only

Current Cancer Drug Targets
Impact Factor History

2-year 3-year 4-year
  • 2023 Impact Factor
    2.34 2.787 2.774
  • 2022 Impact Factor
    2.946 3.171 3.695
  • 2021 Impact Factor
    2.763 3.535 3.442
  • 2020 Impact Factor
    3.095 3.051 2.816
  • 2019 Impact Factor
    2.577 2.646 2.545
  • 2018 Impact Factor
    2.144 2.282 2.49
  • 2017 Impact Factor
    2.203 2.57 3.043
  • 2016 Impact Factor
    2.813 3.706 3.423
  • 2015 Impact Factor
    4.122 4.047 3.845
  • 2014 Impact Factor
    3.871 NA NA
  • 2013 Impact Factor
    3.792 NA NA
  • 2012 Impact Factor
    4.294 NA NA
  • 2011 Impact Factor
    4.758 NA NA
  • 2010 Impact Factor
    4.884 NA NA
  • 2009 Impact Factor
    5.42 NA NA
  • 2008 Impact Factor
    4.545 NA NA
  • 2007 Impact Factor
    5.72 NA NA
  • 2006 Impact Factor
    6.294 NA NA
  • 2005 Impact Factor
    5.804 NA NA
  • 2004 Impact Factor
    5.559 NA NA
  • 2003 Impact Factor
    3.889 NA NA
  • 2002 Impact Factor
    1.5 NA NA
  • 2001 Impact Factor
    0 NA NA
  • 2000 Impact Factor
    NA NA NA
Note: impact factor data for reference only

HIGHEST PAID JOBS

LATEX TUTORIALS

MUST-READ BOOKS


Impact Factor

Impact factor (IF) is a scientometric factor based on the yearly average number of citations on articles published by a particular journal in the last two years. A journal impact factor is frequently used as a proxy for the relative importance of a journal within its field. Find out more: What is a good impact factor?


III. Other Science Influence Indicators

Any impact factor or scientometric indicator alone will not give you the full picture of a science journal. There are also other factors such as H-Index, Self-Citation Ratio, SJR, SNIP, etc. Researchers may also consider the practical aspect of a journal such as publication fees, acceptance rate, review speed. (Learn More)

Current Cancer Drug Targets
H-Index

The h-index is an author-level metric that attempts to measure both the productivity and citation impact of the publications of a scientist or scholar. The index is based on the set of the scientist's most cited papers and the number of citations that they have received in other publications

103

Current Cancer Drug Targets
H-Index History